|
Index of reports
> Disability (42)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Cytarabine disability. The selected reports were submitted to the FDA during the sample period of about a year. Reports 1 - 30 of 42 Next >>
Possible Cytarabine side effects in 17 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-20
Patient: 17 year old female, weighing 42.7 kg (93.9 pounds)
Reactions: Flushing, Oral Pain, Skin Exfoliation, Pain of Skin, Peripheral Sensory Neuropathy
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Etoposide
Dosage: 100 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-09
End date: 2012-07-14
Daunorubicin HCL
Dosage: unk
Indication: Acute Myeloid Leukaemia
Cytarabine
Dosage: 100 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-09
End date: 2012-07-17
Velcade
Dosage: 1.3 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-09
End date: 2012-07-17
Doxorubicin Hydrochloride
Dosage: 50 mg/m2, cyclic
Start date: 2012-06-09
End date: 2012-07-14
Possible Cytarabine side effects in male
Reported by a health professional (non-physician/pharmacist) from Netherlands on 2012-08-17
Patient: male, weighing 68.0 kg (149.6 pounds)
Reactions: Dyspnoea, Vomiting, Nausea, Hyperreflexia, Encephalopathy, Extensor Plantar Response, Endophthalmitis, Lung Consolidation, Respiratory Failure, Emotional Disorder, CSF Pressure Increased, Reflexes Abnormal, Lethargy
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Cytarabine
Dosage: 3600 mg, unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-25
Clofarabine
Dosage: 18 mg, unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-25
Amsacrine
Dosage: 220 mg, unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-28
Other drugs received by patient: Valaciclovir
Possible Cytarabine side effects in 66 year old male
Reported by a physician from France on 2012-08-07
Patient: 66 year old male, weighing 82.0 kg (180.4 pounds)
Reactions: Stenotrophomonas Infection, Coma, Device Related Infection, Pyrexia, Hypernatraemia, Loss of Consciousness, Malaise, Meningeal Disorder, Oedema Peripheral, Eye Movement Disorder, Blood Creatinine Increased, Cough, Hyperphosphataemia, Pleurisy, Pancytopenia, General Physical Health Deterioration, Aplasia, Convulsion, Nephrogenic Diabetes Insipidus, Neutropenia, Citrobacter Infection, Generalised Oedema, Hyperuricaemia, Myalgia, Weight Increased, Pleural Effusion, Crepitations, Thrombocytopenia, Jugular Vein Thrombosis, Candidiasis, Renal Failure Acute, Dyspnoea, Mucosal Inflammation, Diarrhoea, Monoparesis, Inflammation
Adverse event resulted in: death, life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Treanda
Dosage: 180 mg/m2 daily; 358.5 mg on day 1 + 2 of each cycle
Indication: Bone Marrow Conditioning Regimen
Start date: 2012-02-27
End date: 2012-02-28
Melphalan Hydrochloride
Dosage: 250 mg total dose
Indication: Bone Marrow Conditioning Regimen
Start date: 2012-03-03
Cytarabine
Indication: Bone Marrow Conditioning Regimen
Start date: 2012-02-28
End date: 2012-03-02
Etoposide
Dosage: 400 mg/m2 daily; uid/qd
Indication: Bone Marrow Conditioning Regimen
Start date: 2012-02-28
End date: 2012-03-02
Treanda
Indication: non-Hodgkin's Lymphoma
Possible Cytarabine side effects in 65 year old male
Reported by a physician from France on 2012-08-06
Patient: 65 year old male, weighing 74.0 kg (162.8 pounds)
Reactions: Oedema Peripheral, Pancytopenia, Blood Creatinine Increased, Generalised Oedema, Renal Failure Acute
Adverse event resulted in: life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Treanda
Dosage: 200 mg/kg daily; day 1 and 2 of each cycle
Indication: Bone Marrow Conditioning Regimen
Start date: 2012-03-05
Etoposide
Dosage: 380 mg from day 2 to day 5
Indication: Bone Marrow Conditioning Regimen
Start date: 2012-03-06
Rituximab
Indication: Bone Marrow Conditioning Regimen
Start date: 2012-03-06
Cytarabine
Dosage: continuous infusion w/syringe driver 775 mg/day-day 2 to 5
Indication: Bone Marrow Conditioning Regimen
Other drugs received by patient: Melphalan Hydrochloride
Possible Cytarabine side effects in 17 year old female
Reported by a physician from United States on 2012-08-03
Patient: 17 year old female, weighing 42.7 kg (93.9 pounds)
Reactions: Flushing, Skin Exfoliation, Oral Pain, Pain of Skin, Peripheral Sensory Neuropathy
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Doxorubicin Hydrochloride
Dosage: 50 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-09
End date: 2012-07-14
Cytarabine
Dosage: 100 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-09
End date: 2012-07-17
Etoposide
Dosage: 100 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-09
End date: 2012-07-14
Velcade
Dosage: 1.3 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-09
End date: 2012-07-17
Daunorubicin HCL
Dosage: unk
Indication: Acute Myeloid Leukaemia
Possible Cytarabine side effects in 68 year old male
Reported by a physician from Italy on 2012-07-18
Patient: 68 year old male
Reactions: Tumour Lysis Syndrome, Renal Failure, Respiratory Failure, Haematuria, Febrile Bone Marrow Aplasia, Sinus Tachycardia
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Cytarabine
Dosage: 200 mg, daily
Indication: Acute Myeloid Leukaemia
Start date: 2012-02-24
End date: 2012-03-01
Idarubicin Hydrochloride
Dosage: 24 mg, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-02-24
End date: 2012-02-28
Other drugs received by patient: Levofloxacin; Allopurinol; Allopurinol; Normase; Mycostatin; Allopurinol; Zofran; Lasix
Possible Cytarabine side effects in female
Reported by a physician from Switzerland on 2012-07-13
Patient: female, weighing 50.0 kg (110.0 pounds)
Reactions: Electrocardiogram QT Prolonged
Adverse event resulted in: life threatening event, disablity
Drug(s) suspected as cause:
Amsacrine
Dosage: 185 mg, unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-27
End date: 2012-06-27
Cytarabine
Dosage: 1540 mg, qd
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-26
End date: 2012-06-27
Clofarabine
Dosage: 15.4 mg, qd
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-26
End date: 2012-06-26
Amsacrine
Dosage: 185 mg, unk
Start date: 2012-06-27
Other drugs received by patient: Lorazepam; Methylprednisolone; Allopurinol; Ondansetron HCL; Ranitidine
Possible Cytarabine side effects in 72 year old male
Reported by a health professional (non-physician/pharmacist) from Italy on 2012-06-25
Patient: 72 year old male
Reactions: Blood Urine Present, Renal Failure, Tumour Lysis Syndrome, Respiratory Failure, Febrile Bone Marrow Aplasia, Sinus Tachycardia
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Idarubicin Hydrochloride
Dosage: 24 mg, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-02-24
End date: 2012-02-28
Cytarabine
Dosage: 200 mg milligram(s) intravenous (not otherwise specified)
Indication: Acute Myeloid Leukaemia
Start date: 2012-02-24
End date: 2012-03-01
Other drugs received by patient: Lasix; Mycostatin; (Normase); Allopurinol; Zofran; Levofloxacin
Possible Cytarabine side effects in 68 year old male
Reported by a physician from Italy on 2012-06-14
Patient: 68 year old male
Reactions: Renal Failure, Tumour Lysis Syndrome, Respiratory Failure, Haematuria, Febrile Bone Marrow Aplasia, Sinus Tachycardia
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Idarubicin Hydrochloride
Dosage: 24 mg, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-02-24
End date: 2012-02-28
Cytarabine
Dosage: 200 mg, daily
Indication: Acute Myeloid Leukaemia
Start date: 2012-02-24
End date: 2012-03-01
Other drugs received by patient: Lasix; Normase; Allopurinol; Zofran; Allopurinol; Levofloxacin; Mycostatin; Allopurinol
Possible Cytarabine side effects in 72 year old male
Reported by a health professional (non-physician/pharmacist) from Italy on 2012-06-14
Patient: 72 year old male
Reactions: Blood Urine Present, Tachycardia, Pericardial Effusion, Haemoglobin Decreased, Renal Failure, Tumour Lysis Syndrome, Respiratory Failure, Febrile Bone Marrow Aplasia, Pleural Effusion
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Cytarabine
Dosage: 200 mg milligram(s), intravenous (not otherwise specified)
Indication: Acute Myeloid Leukaemia
Start date: 2012-02-24
End date: 2012-03-01
Idarubicin Hydrochloride
Dosage: 24 mg, cyclic, intravenous (not otherwise specified)
Indication: Acute Myeloid Leukaemia
Start date: 2012-02-24
End date: 2012-02-28
Other drugs received by patient: (Normase); Mycostatin; Levofloxacin; Zofran; Allopurinol; Lasix
Possible Cytarabine side effects in 72 year old male
Reported by a health professional (non-physician/pharmacist) from Italy on 2012-06-11
Patient: 72 year old male
Reactions: Renal Failure, Tumour Lysis Syndrome, Respiratory Failure, Haematuria, Febrile Bone Marrow Aplasia, Pleural Effusion, Troponin Increased, Sinus Tachycardia, Pericardial Effusion
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Cytarabine
Dosage: 200 mg milligram(s), intravenous
Indication: Acute Myeloid Leukaemia
Start date: 2012-02-24
End date: 2012-03-01
Idarubicin Hydrochloride
Dosage: 24 mg, cyclic, intravenous
Indication: Acute Myeloid Leukaemia
Start date: 2012-02-24
End date: 2012-02-28
Other drugs received by patient: Normase; Levofloxacin; Allopurinol; Mycostatin; Lasix; Zofran
Possible Cytarabine side effects in 47 year old female
Reported by a health professional (non-physician/pharmacist) from France on 2012-06-04
Patient: 47 year old female
Reactions: Cerebellar Syndrome
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Cytarabine
Dosage: 3000 mg/m2, 2x/day, consolidation
Indication: Acute Myeloid Leukaemia
Start date: 2012-04-18
End date: 2012-04-22
Vancomycin
Dosage: 1.5 g, 1x/day
Start date: 2012-04-19
Other drugs received by patient: Pantoprazole; Piperacillin / Tazobactam Kabi; Neupogen; Chlormadinone Acetate TAB; Vfend; MAG 2
Possible Cytarabine side effects in 68 year old male
Reported by a physician from Italy on 2012-06-04
Patient: 68 year old male
Reactions: Renal Failure, Tumour Lysis Syndrome, Respiratory Failure, Haematuria, Febrile Bone Marrow Aplasia, Sinus Tachycardia
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Cytarabine
Dosage: 200 mg, daily
Indication: Acute Myeloid Leukaemia
Start date: 2012-02-24
End date: 2012-03-01
Idarubicin Hydrochloride
Dosage: 24 mg, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-02-24
End date: 2012-02-28
Other drugs received by patient: Levofloxacin; Lasix; Allopurinol; Normase; Zofran; Allopurinol; Allopurinol; Mycostatin
Possible Cytarabine side effects in female
Reported by a physician from United States on 2012-05-25
Patient: female
Reactions: Lung Consolidation, Osteonecrosis, Joint Range of Motion Decreased, Arthralgia, Limb Asymmetry, Gait Disturbance
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Cytarabine
Dosage: intrathecal
Indication: Acute Lymphocytic Leukaemia
Daunorubicin HCL
Indication: Acute Lymphocytic Leukaemia
Doxorubicin HCL
Indication: Acute Lymphocytic Leukaemia
Cyclophosphamide
Indication: Acute Lymphocytic Leukaemia
Mercaptopurine
Indication: Acute Lymphocytic Leukaemia
Vincristine Sulfate
Indication: Acute Lymphocytic Leukaemia
Dexamethasone
Dosage: intrathecal
Indication: Acute Lymphocytic Leukaemia
Methotrexate
Dosage: intrathecal
Indication: Acute Lymphocytic Leukaemia
Oncaspar
Indication: Acute Lymphocytic Leukaemia
Thioguanine
Indication: Acute Lymphocytic Leukaemia
Possible Cytarabine side effects in 68 year old male
Reported by a physician from Italy on 2012-05-10
Patient: 68 year old male
Reactions: Renal Failure, Tumour Lysis Syndrome, Respiratory Failure, Haematuria, Febrile Bone Marrow Aplasia, Sinus Tachycardia
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Cytarabine
Dosage: 200 mg, daily
Indication: Acute Myeloid Leukaemia
Start date: 2012-02-24
End date: 2012-03-01
Idarubicin Hydrochloride
Dosage: 24 mg, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-02-24
End date: 2012-02-28
Other drugs received by patient: Allopurinol; Allopurinol; Zofran; Allopurinol; Normase; Levofloxacin; Lasix; Mycostatin
Possible Cytarabine side effects in 72 year old male
Reported by a health professional (non-physician/pharmacist) from Italy on 2012-05-07
Patient: 72 year old male
Reactions: Tumour Lysis Syndrome, Renal Failure, Respiratory Failure, Pleural Effusion, Febrile Bone Marrow Aplasia, Sinus Tachycardia, Pericardial Effusion
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Cytarabine
Dosage: 200 mg milligram(s), intravenous
Indication: Acute Myeloid Leukaemia
Start date: 2012-02-24
End date: 2012-03-01
Idarubicin Hydrochloride
Dosage: 24 mg, cyclic intravenous (not otherwise specified)
Indication: Acute Myeloid Leukaemia
Start date: 2012-02-24
End date: 2012-02-28
Other drugs received by patient: Levofloxacin; (Mycosatatin); (Normase); Zofran; Lasix; Allopurinol
Possible Cytarabine side effects in 68 year old male
Reported by a physician from Italy on 2012-05-03
Patient: 68 year old male
Reactions: Renal Failure, Tumour Lysis Syndrome, Respiratory Failure, Haematuria, Febrile Bone Marrow Aplasia, Sinus Tachycardia
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Cytarabine
Dosage: 200 mg, daily
Indication: Acute Myeloid Leukaemia
Start date: 2012-02-24
End date: 2012-03-01
Idarubicin Hydrochloride
Dosage: 24 mg, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-02-24
End date: 2012-02-28
Other drugs received by patient: Mycostatin; Allopurinol; Levofloxacin; Normase; Lasix; Allopurinol; Allopurinol; Zofran
Possible Cytarabine side effects in female
Reported by a physician from United Kingdom on 2012-05-03
Patient: female
Reactions: Eye Infection Toxoplasmal, Neutropenia, Uveitis
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Etoposide
Dosage: unk
Indication: Acute Myeloid Leukaemia
Start date: 2011-08-09
End date: 2011-11-29
Cytarabine
Dosage: unk
Administration route: Oral
Indication: Acute Myeloid Leukaemia
Start date: 2011-08-09
End date: 2011-11-29
Everolimus
Dosage: unk
Administration route: Oral
Indication: Acute Myeloid Leukaemia
Start date: 2011-08-09
End date: 2011-11-29
Daunorubicin Hydrochloride
Dosage: unk
Indication: Acute Myeloid Leukaemia
Start date: 2011-08-09
End date: 2011-11-29
Other drugs received by patient: Ondansetron; Codeine; Vancomycin; Bisacodyl; Fluconazole; Docusate Sodium; Citalopram; Citalopram; Cyclizine; Phosphate-Sandoz; Metamucil-2; Zopiclone; Posaconazole; Nilstat; Pyrimethamine TAB; Acyclovir; Slow-K; Granulocyte Colony Stimulating Factor; Sulphadiazine; Scopolamine
Possible Cytarabine side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-04-24
Patient:
Reactions: Neurotoxicity
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Doxorubicin HCL
Indication: Diffuse Large B-Cell Lymphoma
Cyclophosphamide
Indication: Mantle Cell Lymphoma
Etoposide
Indication: Mantle Cell Lymphoma
Etoposide
Indication: Diffuse Large B-Cell Lymphoma
Tositumomab-Iodine 131
Indication: Diffuse Large B-Cell Lymphoma
Rituximab
Indication: Mantle Cell Lymphoma
Cytarabine
Indication: Mantle Cell Lymphoma
Doxorubicin HCL
Indication: Mantle Cell Lymphoma
Cyclophosphamide
Indication: Diffuse Large B-Cell Lymphoma
Rituximab
Indication: Diffuse Large B-Cell Lymphoma
Cytarabine
Indication: Diffuse Large B-Cell Lymphoma
Tositumomab-Iodine 131
Indication: Mantle Cell Lymphoma
Possible Cytarabine side effects in female
Reported by a physician from United Kingdom on 2012-03-29
Patient: female
Reactions: Eye Infection Toxoplasmal, Uveitis
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Cytarabine
Dosage: unk
Administration route: Oral
Indication: Acute Myeloid Leukaemia
Start date: 2011-05-09
End date: 2011-11-29
Etoposide
Dosage: unk
Indication: Acute Myeloid Leukaemia
Start date: 2011-05-09
End date: 2011-11-29
Daunorubicin HCL
Dosage: unk
Indication: Acute Myeloid Leukaemia
Start date: 2011-05-09
End date: 2011-11-29
Everolimus
Dosage: unk
Administration route: Oral
Indication: Acute Myeloid Leukaemia
Start date: 2011-05-09
End date: 2011-11-29
Other drugs received by patient: Nilstat; Slow-K; Ondansetron; Voriconazole; Vancomycin; Phosphate-Sandoz; Cyclizine; Scopolamine; Citalopram Hydrobromide; Fluconazole; Neupogen; Acyclovir; Codeine Sulfate; Zopiclone
Possible Cytarabine side effects in 51 year old female
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-03-29
Patient: 51 year old female, weighing 29.9 kg (65.9 pounds)
Reactions: Myalgia, Neuropathy Peripheral, Mobility Decreased, Paraesthesia
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Cytarabine
Dosage: 186 mg milligram(s), intravenous, 175 mg milligram(s), intravenous
Indication: Acute Myeloid Leukaemia
Start date: 2011-11-09
End date: 2011-11-09
Cytarabine
Dosage: 186 mg milligram(s), intravenous, 175 mg milligram(s), intravenous
Indication: Acute Myeloid Leukaemia
Start date: 2011-12-29
End date: 2011-12-29
Other drugs received by patient: Acyclovir; (Zopiclone); Gabapentin; Ondansetron; Allopurinol; Daunorubicin HCL; Estradiol; Lorazepam; Midodrine Hydrochloride; Acetaminophen; Thiamine HCL; Lansoprazole; Pregabalin; Itraconazole; Fludrocortisone Acetate; Metoclopramide; (Sando K / 00031402 / ); (Vitamin B Compound / 00212701 / )
Possible Cytarabine side effects in 71 year old female
Reported by a health professional (non-physician/pharmacist) from Germany on 2012-03-26
Patient: 71 year old female, weighing 70.0 kg (154.0 pounds)
Reactions: Multi-Organ Failure, Cytotoxic Cardiomyopathy
Adverse event resulted in: death, hospitalization, disablity
Drug(s) suspected as cause:
Vidaza
Dosage: 135 milligram
Start date: 2011-01-11
End date: 2011-01-15
Daunorubicin HCL
Dosage: 112 milligram
Start date: 2011-02-11
End date: 2011-02-13
Daunorubicin HCL
Dosage: 60 milligram/sq. meter
Start date: 2011-04-13
End date: 2011-04-15
Cytarabine
Start date: 2011-01-16
End date: 2011-01-22
Cytarabine
Dosage: 186 milligram
Start date: 2011-02-09
End date: 2011-02-15
Daunorubicin HCL
Dosage: 112 milligram
Start date: 2011-01-18
End date: 2011-01-20
Vidaza
Dosage: 135 milligram
Start date: 2011-02-04
End date: 2011-02-08
Vidaza
Dosage: 135 milligram
Start date: 2011-04-06
End date: 2011-04-10
Cytarabine
Dosage: 36 gram
Start date: 2011-04-11
End date: 2011-04-26
Other drugs received by patient: Tazobactam; Tazobactam; Meropenem; Tazobactam; Vancomycin; Meropenem; Vancomycin
Possible Cytarabine side effects in 71 year old female
Reported by a health professional (non-physician/pharmacist) from Germany on 2012-03-21
Patient: 71 year old female, weighing 70.0 kg (154.0 pounds)
Reactions: Multi-Organ Failure, Cytotoxic Cardiomyopathy
Adverse event resulted in: death, hospitalization, disablity
Drug(s) suspected as cause:
Cytarabine
Dosage: 36 gram
Start date: 2011-04-11
End date: 2011-04-26
Vidaza
Dosage: 135 milligram
Start date: 2011-02-04
End date: 2011-02-08
Vidaza
Dosage: 135 milligram
Start date: 2011-01-11
End date: 2011-01-15
Daunorubicin HCL
Dosage: 60 milligram/sq. meter
Start date: 2011-04-13
End date: 2011-04-15
Vidaza
Dosage: 135 milligram
Start date: 2011-04-06
End date: 2011-04-10
Daunorubicin HCL
Dosage: 112 milligram
Start date: 2011-01-18
End date: 2011-01-20
Cytarabine
Dosage: 186 milligram
Start date: 2011-02-09
End date: 2011-02-15
Daunorubicin HCL
Dosage: 112 milligram
Start date: 2011-02-11
End date: 2011-02-13
Cytarabine
Start date: 2011-01-16
End date: 2011-01-22
Other drugs received by patient: Tazobactam; Tazobactam; Vancomycin; Meropenem; Meropenem; Tazobactam; Vancomycin
Possible Cytarabine side effects in 39 year old male
Reported by a health professional (non-physician/pharmacist) from France on 2012-03-20
Patient: 39 year old male
Reactions: Facial Paresis, Deafness Bilateral, Visual Acuity Reduced, Hemiparesis
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Cytarabine
Dosage: 2000 mg/m2, cyclic
Indication: non-Hodgkin's Lymphoma
Start date: 2010-12-23
End date: 2011-05-06
Cisplatin
Dosage: 100 mg/m2, monthly
Indication: non-Hodgkin's Lymphoma
Start date: 2010-12-23
End date: 2011-05-04
Other drugs received by patient: Oxaliplatin; Dexamethasone
Possible Cytarabine side effects in female
Reported by a consumer/non-health professional from United States on 2012-03-12
Patient: female
Reactions: Neurotoxicity, Cytogenetic Abnormality, Nervous System Disorder, Dizziness, Ataxia, Fluid Retention
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Gleevec
Dosage: 600 mg, qd
Administration route: Oral
Indication: Acute Lymphocytic Leukaemia
Start date: 2010-10-11
End date: 2010-12-23
Cytarabine
Gleevec
Dosage: 600 mg, qd
Administration route: Oral
Indication: Chromosome Analysis Abnormal
Start date: 2010-11-08
Gleevec
Dosage: 300 mg, qd
Administration route: Oral
Other drugs received by patient: Methotrexate; Chemotherapeutics NOS; Zofran; Flexium
Possible Cytarabine side effects in male
Reported by a health professional (non-physician/pharmacist) from Denmark on 2012-03-12
Patient: male, weighing 15.0 kg (33.0 pounds)
Reactions: Tachycardia, Deafness, Encephalitis, Pyrexia, Poor Quality Sleep, Hypokinesia, Balance Disorder, Leukoencephalopathy, Hypotension, Abnormal Behaviour, General Physical Health Deterioration, Ataxia, Anxiety, Limb Discomfort, Neoplasm Malignant, Tendon Disorder, Disturbance in Attention, Stenotrophomonas Sepsis, Gait Disturbance, Asthenia
Adverse event resulted in: death, hospitalization, disablity
Drug(s) suspected as cause:
Methotrexate
Indication: Acute Myeloid Leukaemia
Start date: 2009-12-02
End date: 2010-05-26
Cytarabine
Indication: Acute Myeloid Leukaemia
Start date: 2009-12-05
End date: 2010-05-27
Other drugs received by patient: Etopophos Preservative Free
Possible Cytarabine side effects in 51 year old female
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-02-28
Patient: 51 year old female, weighing 29.9 kg (65.9 pounds)
Reactions: Myalgia, Neuropathy Peripheral, Paraesthesia
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Cytarabine
Dosage: see image
Indication: Acute Myeloid Leukaemia
Start date: 2011-11-09
End date: 2011-11-09
Cytarabine
Dosage: see image
Indication: Acute Myeloid Leukaemia
Start date: 2011-12-29
End date: 2011-12-29
Other drugs received by patient: Midodrine Hydrochloride; Pregabalin; Lansoprazole; Metoclopramide; (Vitamin B Compound / 00212701 / ); (Elleste Duct); Fludrocortisone Acetate; Itraconazole; Acyclovir; Gabapentin; Daunorubicin HCL; Acetaminophen; (Zoplicone); Allopurinol; Ondansetron; (Sando K / 00031402 / ); Lorazepam; Thiamine HCL
Possible Cytarabine side effects in 51 year old female
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-02-24
Patient: 51 year old female, weighing 66.0 kg (145.2 pounds)
Reactions: Myalgia, Neuropathy Peripheral, Paraesthesia
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Cytarabine
Dosage: 186 mg, unk
Indication: Acute Myeloid Leukaemia
Start date: 2011-11-09
End date: 2011-11-09
Cytarabine
Dosage: 175 mg, unk
Start date: 2011-12-29
End date: 2011-12-29
Other drugs received by patient: Fludrocortisone; Estradiol; Itraconazole; Pregabalin; Gabapentin; Zopiclone; Sando K; Vitamin B 1-6-12; Metoclopramide; Thiamine; Ondansetron; Paracetamol; Aciclovir; Lansoprazole; Lorazepam; Allopurinol; Daunorubicin; Midodrine
Possible Cytarabine side effects in female
Reported by a physician from France on 2012-02-17
Patient: female, weighing 47.0 kg (103.4 pounds)
Reactions: Acute Myeloid Leukaemia, Bone Marrow Failure, Necrotising Fasciitis, Septic Shock
Adverse event resulted in: death, life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Cytarabine
Dosage: 1450 mg, qdx5
Indication: Acute Myeloid Leukaemia
Start date: 2010-06-28
End date: 2010-07-02
Evoltra
Dosage: 43.5 mg, qdx5
Indication: Acute Myeloid Leukaemia
Start date: 2010-06-29
End date: 2010-07-03
Other drugs received by patient: Imipenem and Cilastatin Sodium; Acupan; Lexomil; Zovirax; Neupogen; Amikacin; Fluconazole; Vancomycin
Possible Cytarabine side effects in 71 year old female
Reported by a health professional (non-physician/pharmacist) from Germany on 2012-02-03
Patient: 71 year old female, weighing 70.0 kg (154.0 pounds)
Reactions: Multi-Organ Failure, Cytotoxic Cardiomyopathy
Adverse event resulted in: death, hospitalization, disablity
Drug(s) suspected as cause:
Cytarabine
Dosage: 186 milligram
Start date: 2011-02-09
End date: 2011-02-15
Daunorubicin HCL
Dosage: 112 milligram
Start date: 2011-01-18
End date: 2011-01-20
Daunorubicin HCL
Dosage: 112 milligram
Start date: 2011-02-11
End date: 2011-02-13
Vidaza
Dosage: 140 milligram
Start date: 2011-02-04
End date: 2011-02-08
Vidaza
Dosage: 135 milligram
Start date: 2011-04-06
End date: 2011-04-10
Vidaza
Dosage: 135 milligram
Start date: 2011-01-11
End date: 2011-01-15
Cytarabine
Start date: 2011-01-16
End date: 2011-01-22
Cytarabine
Dosage: 36 gram
Start date: 2011-04-11
Other drugs received by patient: Tazobactam; Vancomycin; Meropenem; Vancomycin; Tazobactam; Tazobactam; Meropenem
Page 1 Next >>
|
